Cargando…
Immune thrombocytopenic purpura induced by the COVID-19 vaccine after the second dose in a 78-year-old patient: A case report
Coronavirus disease 2019 (COVID-19) has become a global pandemic, but treatment options remain limited. Up to now, vaccination has been the main strategy to prevent transmission and reduce disease severity. However, with follow-up observations after massive vaccination, immune thrombocytopenic purpu...
Autores principales: | Liu, Wenhui, Wu, Tao, Xue, Feng, Tian, Hongjuan, Song, Rui, Bai, Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353547/ https://www.ncbi.nlm.nih.gov/pubmed/35949340 http://dx.doi.org/10.3892/etm.2022.11517 |
Ejemplares similares
-
Immune thrombocytopenic purpura
por: Zainal, Abir, et al.
Publicado: (2019) -
Immune thrombocytopenic purpura and COVID-19 vaccination
por: Joob, Beuy, et al.
Publicado: (2023) -
Immune thrombocytopenic purpura and COVID-19 vaccination
por: Joob, Beuy, et al.
Publicado: (2023) -
Diffuse large B‑cell lymphoma and monoclonal gammopathy secondary to immune thrombocytopenic purpura: A case report
por: Ren, Liwei, et al.
Publicado: (2023) -
Dapsone therapy for immune thrombocytopenic purpura: old but still unfamiliar
por: Song, Jaewoo
Publicado: (2017)